Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency

BJOG. 2007 Nov;114(11):1427-31. doi: 10.1111/j.1471-0528.2007.01511.x.

Abstract

The aim of this study was to investigate whether maternal serum levels of angiopoietin-2 (Ang-2) and pregnancy-associated plasma protein A (PAPP-A) are associated with subsequent intrauterine growth restriction (IUGR). Ang-2 was measured in 29 nonpregnant and 44 pregnant women at 10-13 weeks of gestation. The median concentration of Ang-2 was 26.61 ng/ml in normal pregnant women compared with 1.71 ng/ml in nonpregnant controls (P < 0.01). Women who subsequently developed severe IUGR had lower levels of Ang-2 compared with normal pregnant controls (P < 0.01). PAPP-A levels were similar in all pregnant groups. These findings suggest that Ang-2 should be evaluated for its ability to predict pregnancies that later are affected by IUGR.

Publication types

  • Comparative Study

MeSH terms

  • Angiopoietin-2 / metabolism*
  • Biomarkers / metabolism
  • Birth Weight
  • Female
  • Fetal Growth Retardation / diagnosis*
  • Fetal Growth Retardation / etiology
  • Humans
  • Placental Insufficiency / blood*
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy-Associated Plasma Protein-A / metabolism

Substances

  • Angiopoietin-2
  • Biomarkers
  • Pregnancy-Associated Plasma Protein-A